Overview
Alexis Arzimanoglou practices in Lyon, France. Ms. Arzimanoglou is rated as a Distinguished expert by MediFind in the treatment of Generalized Tonic-Clonic Seizure. Her top areas of expertise are Lennox-Gastaut Syndrome (LGS), Epilepsy, Alternating Hemiplegia of Childhood, and Hemiplegia.
Her clinical research consists of co-authoring 137 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 36 articles in the study of Generalized Tonic-Clonic Seizure.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EpilepsyMs. Arzimanoglou isElite. Learn about Epilepsy.
- Lennox-Gastaut Syndrome (LGS)Ms. Arzimanoglou isElite. Learn about Lennox-Gastaut Syndrome (LGS).
- Distinguished
- Absence SeizureMs. Arzimanoglou isDistinguished. Learn about Absence Seizure.
- Alternating Hemiplegia of ChildhoodMs. Arzimanoglou isDistinguished. Learn about Alternating Hemiplegia of Childhood.
- Epilepsy in ChildrenMs. Arzimanoglou isDistinguished. Learn about Epilepsy in Children.
- Generalized Tonic-Clonic SeizureMs. Arzimanoglou isDistinguished. Learn about Generalized Tonic-Clonic Seizure.
- HemiplegiaMs. Arzimanoglou isDistinguished. Learn about Hemiplegia.
- Hypomelanosis of ItoMs. Arzimanoglou isDistinguished. Learn about Hypomelanosis of Ito.
- Advanced
- CDKL5 Deficiency DisorderMs. Arzimanoglou isAdvanced. Learn about CDKL5 Deficiency Disorder.
- Cortical DysplasiaMs. Arzimanoglou isAdvanced. Learn about Cortical Dysplasia.
- Early Infantile Epileptic EncephalopathyMs. Arzimanoglou isAdvanced. Learn about Early Infantile Epileptic Encephalopathy.
- Epilepsy Juvenile AbsenceMs. Arzimanoglou isAdvanced. Learn about Epilepsy Juvenile Absence.
- Epilepsy with Myoclonic-Atonic SeizuresMs. Arzimanoglou isAdvanced. Learn about Epilepsy with Myoclonic-Atonic Seizures.
- Palatal MyoclonusMs. Arzimanoglou isAdvanced. Learn about Palatal Myoclonus.
- Experienced
- Achalasia Microcephaly SyndromeMs. Arzimanoglou isExperienced. Learn about Achalasia Microcephaly Syndrome.
- Aicardi SyndromeMs. Arzimanoglou isExperienced. Learn about Aicardi Syndrome.
- Arthrogryposis Multiplex CongenitaMs. Arzimanoglou isExperienced. Learn about Arthrogryposis Multiplex Congenita.
- Attention Deficit Hyperactivity Disorder (ADHD)Ms. Arzimanoglou isExperienced. Learn about Attention Deficit Hyperactivity Disorder (ADHD).
- Batten DiseaseMs. Arzimanoglou isExperienced. Learn about Batten Disease.
- Benign Rolandic EpilepsyMs. Arzimanoglou isExperienced. Learn about Benign Rolandic Epilepsy.